Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for BIO-TECHNE (TECH) over the last 9 years, with Sep 2024 value amounting to $1.1 million.

  • BIO-TECHNE's Change in Acquisitions & Divestments fell 95.43% to $1.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $102.4 million, marking a year-over-year decrease of 16.78%. This contributed to the annual value of $1.1 million for FY2025, which is 96.14% down from last year.
  • As of Q3 2024, BIO-TECHNE's Change in Acquisitions & Divestments stood at $1.1 million, which was down 74.91% from $4.3 million recorded in Q2 2024.
  • In the past 5 years, BIO-TECHNE's Change in Acquisitions & Divestments ranged from a high of $73.2 million in Q3 2022 and a low of $1.1 million during Q3 2024.
  • In the last 3 years, BIO-TECHNE's Change in Acquisitions & Divestments had a median value of $13.6 million in 2022 and averaged $23.2 million.
  • As far as peak fluctuations go, BIO-TECHNE's Change in Acquisitions & Divestments skyrocketed by 488.10% in 2022, and later plummeted by 95.43% in 2024.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Change in Acquisitions & Divestments stood at $14.1 million in 2020, then slumped by 57.13% to $12.4 million in 2021, then soared by 488.10% to $73.2 million in 2022, then tumbled by 67.55% to $23.8 million in 2023, then plummeted by 95.43% to $1.1 million in 2024.
  • Its last three reported values are $1.1 million in Q3 2024, $4.3 million for Q2 2024, and $23.8 million during Q3 2023.